Strontium ranelate in the treatment of knee osteoarthritis: new insights and emerging clinical evidence

Strontium ranelate: ready for clinical use as disease-modifying osteoarthritis drug?

(2013) Floris P J G Lafeber et al.   ANNALS OF THE RHEUMATIC DISEASES

Efficacy and Safety of Strontium Ranelate in the Treatment of Osteoporosis in Men

(2013) J.-M. Kaufman et al.   JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM

European Congress on Osteoporosis and Osteoarthritis (ESCEO13-IOF): Plenary Lecture Abstracts

(2013)   OSTEOPOROSIS INTERNATIONAL

Efficacy and safety of strontium ranelate in the treatment of knee osteoarthritis: results of a double-blind, randomised placebo-controlled trial

(2012) Jean-Yves Reginster et al.   ANNALS OF THE RHEUMATIC DISEASES

Efficacy and safety of oral strontium ranelate for the treatment of knee osteoarthritis: rationale and design of randomised, double-blind, placebo-controlled trial

(2012) Hamid Namazi   CURRENT MEDICAL RESEARCH AND OPINION

Osteoarthritis year 2012 in review: clinical

(2012) M.C. Hochberg   OSTEOARTHRITIS AND CARTILAGE

Estimating the excess costs for patients with incident fractures, prevalent fractures, and nonfracture osteoporosis

(2012) R. B. Hopkins et al.   OSTEOPOROSIS INTERNATIONAL

Clinical significance of bone changes in osteoarthritis

(2012) Tuhina Neogi   Therapeutic Advances in Musculoskeletal Disease

Strontium ranelate inhibits key factors affecting bone remodeling in human osteoarthritic subchondral bone osteoblasts

(2011) Steeve Kwan Tat et al.   BONE

Efficacy and safety of oral strontium ranelate for the treatment of knee osteoarthritis: rationale and design of randomised, double-blind, placebo-controlled trial

(2011) Cyrus Cooper et al.   CURRENT MEDICAL RESEARCH AND OPINION

Osteoarthritis: an update with relevance for clinical practice

(2011) Johannes WJ Bijlsma et al.   LANCET

OARSI-FDA initiative: defining the disease state of osteoarthritis

(2011) N.E. Lane et al.   OSTEOARTHRITIS AND CARTILAGE

Responsiveness to change and reliability of measurement of radiographic joint space width in osteoarthritis of the knee: a systematic review

(2011) W.M. Reichmann et al.   OSTEOARTHRITIS AND CARTILAGE

Summary and recommendations of the OARSI FDA osteoarthritis Assessment of Structural Change Working Group

(2011) P.G. Conaghan et al.   OSTEOARTHRITIS AND CARTILAGE

Maintenance of antifracture efficacy over 10 years with strontium ranelate in postmenopausal osteoporosis

(2011) J-Y. Reginster et al.   OSTEOPOROSIS INTERNATIONAL

Do knee abnormalities visualised on MRI explain knee pain in knee osteoarthritis? A systematic review

(2010) E. Yusuf et al.   ANNALS OF THE RHEUMATIC DISEASES

Targeting subchondral bone for treating osteoarthritis: what is the evidence?

(2010) Steeve Kwan Tat et al.   BEST PRACTICE & RESEARCH IN CLINICAL RHEUMATOLOGY

Strontium ranelate effect in postmenopausal women with different clinical levels of osteoarthritis

(2010) P. Alexandersen et al.   CLIMACTERIC

OARSI recommendations for the management of hip and knee osteoarthritis

(2010) W. Zhang et al.   OSTEOARTHRITIS AND CARTILAGE

Radiologic assessment of age-related knee joint space changes in women: A 4-year longitudinal study

(2009) Déborah Gensburger et al.   ARTHRITIS AND RHEUMATISM

Osteoblasts play key roles in the mechanisms of action of strontium ranelate

(2009) TC Brennan et al.   BRITISH JOURNAL OF PHARMACOLOGY

Bone marrow lesions and joint effusion are strongly and independently associated with weight-bearing pain in knee osteoarthritis: data from the osteoarthritis initiative

(2009) G.H. Lo et al.   OSTEOARTHRITIS AND CARTILAGE

The effect of strontium ranelate on serum insulin like growth factor-1 and leptin levels in osteoporotic post-menopausal women: a prospective study

(2008) Ibrahim Gulhan et al.   ARCHIVES OF GYNECOLOGY AND OBSTETRICS

Comorbidity, limitations in activities and pain in patients with osteoarthritis of the hip or knee

(2008) Gabriella M van Dijk et al.   BMC MUSCULOSKELETAL DISORDERS

Should subchondral bone turnover be targeted when treating osteoarthritis?

(2008) M.A. Karsdal et al.   OSTEOARTHRITIS AND CARTILAGE

Strontium ranelate treatment of human primary osteoblasts promotes an osteocyte-like phenotype while eliciting an osteoprotegerin response

(2008) G. J. Atkins et al.   OSTEOPOROSIS INTERNATIONAL